118 related articles for article (PubMed ID: 4198706)
1. A novel monoquaternary neuromuscular blocking agent.
Bamford DG; Biggs DF; Chaplen P; Davis M; Maconochie J
Experientia; 1972 Sep; 28(9):1069-70. PubMed ID: 4198706
[No Abstract] [Full Text] [Related]
2. Recovery from neuromuscular blockade during single shock and tetanic nerve stimulation in cats.
Hughes R
Br J Anaesth; 1970 Jul; 42(7):564-72. PubMed ID: 4247669
[No Abstract] [Full Text] [Related]
3. On the role of the ester groups in the internitrogen chain in the action of bisquaternary compounds on skeletal muscles.
Danilov AF; Guli-Kevkhyan RS; Lavrentieva VV; Michelson MJ; Mndjoyan OL; Shelkovnikov SA; Starshinova LA
Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):35-51. PubMed ID: 4844369
[No Abstract] [Full Text] [Related]
4. The interactions of hexafluorenium with depolarizing and competitive neuromuscular blocking agents.
Scaf AH; van den Akker J; Berends F
Arch Int Pharmacodyn Ther; 1974 Mar; 208(1):166-76. PubMed ID: 4276930
[No Abstract] [Full Text] [Related]
5. Interactions of serotonin with neuromuscular blocking agents.
Dretchen K; Ghoneim MM; Long JP
Eur J Pharmacol; 1972 Apr; 18(1):121-7. PubMed ID: 4260607
[No Abstract] [Full Text] [Related]
6. Quillaiate of choline iodide: a new monoquaternary neuromuscular blocking agent.
Hamed MI; el-Gholmy Z
Arzneimittelforschung; 1972 Dec; 22(12):2133-6. PubMed ID: 4350747
[No Abstract] [Full Text] [Related]
7. Lack of neuromuscular blocking effect of chloramphenicol.
Adams HR; Rossner SD
Am J Vet Res; 1972 May; 33(5):1083-6. PubMed ID: 5023050
[No Abstract] [Full Text] [Related]
8. Neuromuscular blocking agents. Replacement of quaternary ammonium groups in bis-onium compounds by amidinium, guanidinium, thiouronium, sulphonium and sulphoxonium groups.
Bamford DG; Biggs DF; Chaplen P; Davis M
J Pharm Pharmacol; 1970 Feb; 22(2):110-5. PubMed ID: 4392244
[No Abstract] [Full Text] [Related]
9. The neuromuscular blocking properties of the antimalarial agent, bis((chloro-7"-quinolyl-4")amino-2'-propyl)-1,4-piperazine.
Castles TR; Loth E; Crawford CR; Lee CC
J Pharmacol Exp Ther; 1970 Mar; 172(1):44-51. PubMed ID: 5416945
[No Abstract] [Full Text] [Related]
10. Effects of anaesthetics and their interactions with neuromuscular blocking agents in cats.
Hughes R
Br J Anaesth; 1970 Oct; 42(10):826-33. PubMed ID: 4248885
[No Abstract] [Full Text] [Related]
11. Neuromuscular blocking activity of a new series of quaternary N-substituted choline esters.
Ginsburg S; Kitz RJ; Savarese JJ
Br J Pharmacol; 1971 Sep; 43(1):107-26. PubMed ID: 4257628
[TBL] [Abstract][Full Text] [Related]
12. The effect of depolarizing relaxants on the neuromuscular refractory period of anesthetized man.
Epstein RA; Jackson SH
Anesthesiology; 1973 Feb; 38(2):166-72. PubMed ID: 4684514
[No Abstract] [Full Text] [Related]
13. Short-lasting, competitive neuromuscular blocking activity in a series of azobis-arylimidazo-(1,2-a)-pyridinium dihalides.
Bolger L; Brittain RT; Jack D; Jackson MR; Martin LE; Mills J; Poynter D; Tyers MB
Nature; 1972 Aug; 238(5363):354-5. PubMed ID: 4627710
[No Abstract] [Full Text] [Related]
14. Neuromuscular blocking properties of stereoisomeric androstane-3,l7-bisquaternary ammonium salts.
Bamford DG; Biggs DF; Davis M; Parnell EW
Br J Pharmacol Chemother; 1967 May; 30(1):194-202. PubMed ID: 4962751
[No Abstract] [Full Text] [Related]
15. The neuromuscular blocking activity of some monoquaternary androstane derivatives.
Bamford DG; Biggs DF; Davis M; Parnell EW
J Pharm Pharmacol; 1971 Aug; 23(8):595-9. PubMed ID: 4397743
[No Abstract] [Full Text] [Related]
16. [Results of the association of depolarizing and non-depolarizing muscle relaxants].
Foldes FF
Anesth Analg (Paris); 1971; 28(5):859-69. PubMed ID: 4258297
[No Abstract] [Full Text] [Related]
17. AH 8165: a new short-acting, competitive neuromuscular blocking drug.
Brittain RT; Tyers MB
Br J Pharmacol; 1972 May; 45(1):158P-159P. PubMed ID: 4625270
[No Abstract] [Full Text] [Related]
18. Species-dependent effect of neuromuscular blocking agents.
Derkx FH; Bonta IL; Lagendijk A
Eur J Pharmacol; 1971 Sep; 16(1):105-8. PubMed ID: 5157524
[No Abstract] [Full Text] [Related]
19. Effect of fluconazole on neuromuscular transmission.
Hamdan W; Ramzan I
In Vivo; 1993; 7(5):461-2. PubMed ID: 8110992
[TBL] [Abstract][Full Text] [Related]
20. Antinicotinic action of benzyltrimethylammonium bromide (BTM).
Dretchen K; Sokoll MD; Long JP
J Pharmacol Exp Ther; 1971 Jul; 178(1):192-8. PubMed ID: 5087397
[No Abstract] [Full Text] [Related]
[Next] [New Search]
